Search results
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Has Great Upside Potential – Stocks Register
Stocks Register· 10 hours agoTeva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) shares, rose in value on Wednesday, May 15, with the stock price down by -1.81% ...
A company insider recently sold 15,219 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]....
Knox Daily· 10 hours agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Teva- Pharmaceutical Industries Ltd. ADR ...
Piper Sandler bullish on Teva stock on solid pipeline By Investing.com
Investing.com· 3 days agoOn Monday, Piper Sandler confirmed its Overweight rating on Teva Pharmaceutical Industries Limited...
Teva executive sells over $250k in company stock By Investing.com
Investing.com· 1 day agoVikki L. Conway, acting Head of Global Human Resources at Teva Pharmaceutical Industries Ltd. (NYSE:...
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Buy at StockNews.com
ETF DAILY NEWS· 2 days agoBarclays lifted their price target on shares of Teva Pharmaceutical Industries from $17.00 to $20.00 and gave the stock an overweight rating in a report ...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 7 hours agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
Zacks· 4 days agoWhile the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies ...
David Abrams Exits Teva Pharmaceutical in Q1 2024, Reflecting Strategic Portfolio Adjustments
GuruFocus.com via Yahoo Finance· 2 days agoThe first quarter of 2024 has seen significant shifts in his investment strategy, particularly with...
BofA lifts Teva shares target after positive Phase 3 trial results By Investing.com
Investing.com· 6 days agoOn Thursday, BofA Securities adjusted its outlook on Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
Investing in Teva- Pharmaceutical Industries Ltd. ADR
Knox Daily· 3 days agoTeva- Pharmaceutical Industries Ltd. ADR’s recent filing unveils that its EVP, Chief Financial Officer Kalif Eliyahu Sharon unloaded Company’s shares for ...